Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

More in Hematology-Oncology

Researchers announced that two people with HIV infections are now apparently virus free since they received bone-marrow transplants for lymphoma and ceased taking antiretrovirals, The New York Times reports. These two cases, both in Boston, mirror...
The U.S. Food and Drug Administration granted marketing approval for Baxter International‘s Rixubis medication, according to Reuters. Rixubis is a “genetically engineered protein … that represents the first new treatment for [hemophilia...

Reuters Health • The Doctor's Channel Daily Newscast

Survival After Hematopoietic Cell Transplantation Has Improved

NEW YORK (Reuters Health) – Since the mid-90s, early survival rates after allogeneic hematopoietic cell transplantation (alloHCT) among patients with hematologic diseases have improved significantly, based on an analysis of registry data. However,...